Video Instruction for Medication Adherence
Trial Summary
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. However, since the study focuses on teaching self-administration of a specific medication, it seems unlikely that you would need to stop other medications.
What data supports the effectiveness of the drug self-administration of subcutaneous depot medroxyprogesterone?
Research shows that women find self-administering subcutaneous depot medroxyprogesterone acetate (DMPA-SC) to be feasible and acceptable, which suggests that they are likely to continue using it effectively. Additionally, a study on text messaging support for users of a similar injectable contraceptive found that reminders can improve appointment attendance, indicating that support tools may enhance adherence to this drug.12345
Is self-administered subcutaneous depot medroxyprogesterone safe for humans?
How does the video instruction treatment for medication adherence differ from other treatments?
What is the purpose of this trial?
This is a study to determine if a video that utilizes a peer to teach self administration of subcutaneous depot medroxyprogesterone is both effective and well accepted by adolescent patients who are already receiving ongoing treatment with depot medroxyprogesterone by a medical provider via an inter muscular injection. Self administration can be done at home and therefore offers an alternative to traveling to a medical office.
Eligibility Criteria
This trial is for young individuals assigned female at birth, aged 19 or younger, who have had at least one injection of depot medroxyprogesterone. They must not be wards of the state or prisoners and should have a guardian to consent if under 18. They can't join if they've self-injected before, never had this medication, are pregnant, don't understand English, can't watch the video or have cognitive issues.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Initial Visit and Training
Participants watch a peer-to-peer instructional video and perform a supervised self-injection of subcutaneous depot-medroxyprogesterone
Follow-up
Participants complete a follow-up survey and self-report on sustained self-injection practices
Treatment Details
Interventions
- Self-administration of subcutaneous depot medroxyprogesterone
Find a Clinic Near You
Who Is Running the Clinical Trial?
Tufts Medical Center
Lead Sponsor